Skip directly to search Skip directly to A to Z list Skip directly to site content

PUBLIC HEALTH ASSESSMENT

REVERE CHEMICAL COMPANY
NOCKAMIXON, BUCKS COUNTY, PENNSYLVANIA

CONCLUSIONS

Based on the information reviewed, PADOH has concluded that this site is an indeterminatepublic health hazard. Available data do not indicate that humans are being or have been exposedto levels of contaminants that would be expected to cause adverse health effects. However,groundwater flow has not been fully characterized and not all residential wells in close proximityof the site have been tested. Residential well testing has been completed under the Phase 2AGroundwater Investigation and the outcome is under review (12). The highest on-sitecontamination occurred in the "process area" of the site and this area is fenced and not accessibleto the public. There were no community health concerns regarding mortality or morbidity.

Lead was found in an upgradient residential well above the USEPA proposed guideline of 15ยตg/L at the tap. This represents a non-site-related public health problem.

RECOMMENDATIONS

Site Characterization Recommendations

    Conduct routine monitoring of nearby residential wells for the presence of lead and site-relatedcontaminants to determine if site-related contaminants are migrating.

Health Activities Recommendations Panel (HARP) Recommendations

    The data and information developed in the Revere Chemical Public Health Assessment havebeen evaluated for appropriate follow-up health actions. The ATSDR Health ActivitiesRecommendation Panel (HARP) determined that no follow-up public health actions arenecessary. ATSDR will reevaluate this site and conduct appropriate public health actions, if newdata become available that indicate a need to do so.

PUBLIC HEALTH ACTIONS

The Public Health Action Plan (PHAP) for the Revere Chemical site contains a description ofactions to be taken by ATSDR and/or PADOH at and in the vicinity of the site subsequent to thecompletion of this public health assessment. For those actions already taken at the site, pleasesee the Background section of this public health assessment. The purpose of the PHAP is toensure that this public health assessment not only identifies public health hazards, but provides aplan of action designed to mitigate and prevent adverse human health effects resulting fromexposure to hazardous substances in the environment. Included, is a commitment on the part ofATSDR/PADOH to follow-up on this plan to ensure that it is implemented. The public healthactions to be implemented by ATSDR/PADOH are as follows:

  1. PADOH will continue to review off-site residential well sampling data to determine if any site-related contaminants are migrating.
  2. ATSDR will provide a follow-up to this PHAP, outlining the actions completed and those inprogress. This report will be placed in repositories that contain copies of this public healthassessment, and will be provided to persons who request it.

ATSDR will reevaluate and expand the Public Health Action Plan when needed. Newenvironmental, toxicological, or health outcome data, or the results of implementing the aboveproposed actions may determine the need for additional actions at this site.

PUBLIC COMMENTS AND RESPONSE

A comment was received which provided clarification and a minor editorial correction to thereport. A minor editorial correction was made to the off-site contamination section of the reportbased on the clarification received.

PREPARERS OF REPORT

Thomas Hartman
Statistician
Pennsylvania Department of Health

Kandiah Sivarajah, Ph.D.
State Toxicologist and Project Director
Pennsylvania Department of Health

ATSDR Regional Representative:

Charles Walters
Public Health Advisor
USEPA Region III
Office of the Assistant Administrator

ATSDR Technical Project Officer:

Gregory Ulirsch/Gail Godfrey
Technical Project Officers
Remedial Program Branch
Division of Health Assessment and Consultation

CERTIFICATION

This Revere Chemical Company Public Health Assessment was prepared by the Department ofHealth under a cooperative agreement with the Agency for Toxic Substances and DiseaseRegistry (ATSDR). It is in accordance with approved methodology and procedures existing atthe time the public health assessment was begun.

Gail Godfrey
Technical Project Officer
Remedial Programs Branch
Division of Health Assessment and Consultation (DHAC)
ATSDR

The Division of Health Assessment and Consultation, ATSDR, has reviewed this public healthassessment, and concurs with its findings.

Robert C. Williams, P.E., DEE
Director, DHAC, ATSDR

REFERENCES

  1. Phase II Remedial Investigation Draft Report, Revere Chemical Site, Nockamixon Township, Pennsylvania, Dames & Moore, October 21, 1991.
  2. Phase I Remedial Investigation, Revere Chemical Site, Nockamixon Township, Pennsylvania, Dames & Moore, March 14, 1990.
  3. Summary of General Population Characteristics 1990, Census of Population and Housing, 1990; Summary Tape File 1A, U.S. Department of Commerce, Bureau of the Census, June 1991.
  4. Agency for Toxic Substances and Disease Registry. Draft Health Assessment for Revere Chemical Company, Revere, Bucks County, Pennsylvania, 1988.
  5. Public Schools, Elementary Enrollments, 1990-1991, Pennsylvania Department of Education, 1991.
  6. Public Schools, Secondary Enrollments, 1990-1991, High School Graduates, 1989-1990, Pennsylvania Department of Education, 1991.
  7. Nursing Home Directory, State Health Data Center, Pennsylvania Department of Health, December 1990.
  8. Directory of Pennsylvania Hospitals, State Health Data Center, Pennsylvania Department of Health, December 1990.
  9. Rand McNally & Company, Pennsylvania, Commercial Reference Map and Guide, 1983.
  10. Telephone Conversation with Ruth Rzepski, Remedial Program Manager, U.S. EPA, June 19, 1992.
  11. Hydrogeological Evaluation by J.E. Godfrey, Hydrogeologist, Pennsylvania Department of Health, August 1992.
  12. Telephone Conversation with Ruth Rzepski, Remedial Program Manager, U.S. EPA, August 1992.
  13. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Lead. Atlanta, Georgia; Agency for Toxic Substances and Disease Registry, June 1990, DHHS Publication No. (PHS) TP-88-17.
  14. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Trichloroethene, U.S. Public Health Service, Atlanta, Georgia, October 1989.
  15. Sittig, Marshall. Handbook of Toxic and Hazardous Chemicals and Carcinogens, 3rdEdition, Noyes Publication, 1991.


APPENDIX A. Figures

Figure 1
Figure 1.

Figure 2
Figure 2.

Figure 3
Figure 3.

Figure 4
Figure 4.

Figure 5
Figure 5.

Figure 6
Figure 6.


APPENDIX B. Tables

This Appendix was not available in electronic format for conversion to HTML at the time of preparation of this document. To obtain a hard copy of the document, please contact:

    Agency for Toxic Substances and Disease Registry
    Division of Health Assessment and Consultation
    Attn: Chief, Program Evaluation, Records, and Information Services Branch,
    MS E-56
    1600 Clifton Road NE,
    Atlanta, Georgia 30333


Table of Contents

  
 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Agency for Toxic Substances and Disease Registry, 4770 Buford Hwy NE, Atlanta, GA 30341
Contact CDC: 800-232-4636 / TTY: 888-232-6348

A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #